2-Methyl-5-Nitro-1H-Isoindole-1,3(2H)-Dione Manufacturer

Valentis Laboratories is a contract development and manufacturing organization (CDMO) headquartered in Telangana, India and has developed expertise in the synthesis and manufacture of niche APIs, intermediates and speciality compounds. The company, which partners with pharmaceutical manufacturers in India and overseas, says its products are used as key ingredients in medicines for therapeutic areas such as antidepressants, antibiotics and antifungals.

The company’s strategy brings together research, production, testing, quality and supporting infrastructure. This integrated model allows Valentis to develop products from process development to manufacturing with emphasis on technical and quality requirements.

Valentis is committed to providing reliable solutions for pharmaceutical and specialty chemical applications, with an emphasis on innovation and customer requirements.

Valentis has a wide product portfolio in APIs, pharmaceutical intermediates and speciality compounds. Its product portfolio comprises established pharmaceutical ingredients and chemical building blocks for use in synthesis.

Active Pharmaceutical Ingredients : Active Pharmaceutical Ingredients , or APIs , are the active ingredients that provide the desired effect of a drug . These APIs are connected to drugs used in several therapeutic areas including treatments for depression and fungal infections.

The API portfolio includes:

• Bupropion HCl, USP
• Fluconazole USP/IP
• Itraconazole BP/IP
• Ketoconazole USP/BP

Pharmaceutical Intermediates: Intermediates are chemicals used during the process of making APIs. These are important building blocks as the quality and consistency of an intermediate can affect subsequent synthesis and the final product.

This involves:

• Metachloropropiophenone
• 3-Chloropropiophenone
• Chloroacetyl Chloride
• Trichloroacetyl Chloride
• Methyl Monochloroacetate
• Benzyl Ethyl Chloride

The company also produces intermediates for the synthesis of Itraconazole and Fluconazole.

2-Methyl-5-Nitro-1H-Isoindole-1,3(2H)-Dione is a speciality pharmaceutical chemical with CAS 644-02-0. It is also known as 4-Nitro-N-methylphthalimide or N-Methyl-4-nitrophthalimide. Its CAS no. is 41663-84-7.

This compound is a member of the phthalimide family and is mainly found as a chemical and pharmaceutical intermediate. It is used as an intermediate in pharmaceutical, pesticide and dye related chemistry.

Typical uses and applications are:

• Pharmaceutical Intermediate: A basis for chemical synthesis and research
• Speciality Chemical Synthesis: For the development and preparation of other organic compounds.
• Pesticide-Related Chemistry: Registered with chemical suppliers as an intermediate for some agrochemical applications.
• Dye and Fine Chemical Research: Can be used as an intermediate for the speciality organic syntheses.
• Analytical and Research Uses: The compound may be analysed by chromatographic methods such as HPLC and used for impurity separation and preparative analysis.

As the scope of industries widens, we are a highly regarded 2-Methyl-5-nitro-1H-isoindole-1,3 (2H)-dione Manufacturer in the market.

Valentis has a strong research and development component to its operating model. The company constantly invests in R&D to develop innovative approaches with customer requirements at the center of its work. It has more than 30 scientists who are behind its R&D and manufacturing.

The company’s own R&D activities include:

• Developing new and low-cost non-infringing processes
• Synthesis of chiral, complex and niche molecules
• Trying out new ways of doing things at various stages of development
• Developing greener processes and effluent-management approaches
• Identification and characterisation of potential contaminants
• Cost reduction and quality improvement toward

This research-driven approach allows Valentis to address particular synthesis requirements, making us a highly recommended 2-Methyl-5-nitro-1H-isoindole-1,3 (2H)-dione Manufacturer.

The manufacture of pharmaceuticals and speciality chemicals requires appropriate equipment, facilities and process controls. Valentis has developed infrastructure within its operations to support research, production, quality control, testing, packaging and storage.

Its infrastructure highlights include:

• Quality Control Laboratory Integrated
• Stability chambers for long-term and accelerated studies
• Class 100,000 clean rooms
• Nitrogen plants
• Several drying systems and micronisers
• Separate areas for drying and packing
• High vacuum distillation units
• Boilers, chilling plants, hot oil circulation systems

The company also says that part of its manufacturing strategy includes backward integration and optimisation of facilities and utilities.

Specialized pharmaceutical chemistry normally involves controlled reactions and experience with complex processing conditions. Valentis is knowledgeable about a wide variety of chemical reactions and synthetic techniques.

It claims expertise in the areas of:

• Reactions of Grignard and Friedel-Crafts
• Nitration and catalytic reductions
• Aliphatic and aromatic chemistry
• Condensation and addition reaction
• Reactions to cryogenic and pressure
• Stereoselective asymmetric synthesis
• Chirality chemistry
• Dealing with some hazardous reagents

These capabilities have made us the preferred source for a high-performing 2-Methyl-5-nitro-1H-isoindole-1,3 (2H)-dione Manufacturer.

Quality is central to pharmaceutical manufacturing where consistency and analytical control are paramount. Valentis says it adheres to a full quality approach with extensive impurity profiling and product analysis.

Its Quality Control laboratories are provided with analytical systems like:

• High Performance Liquid Chromatography (HPLC)
• Headspace & normal GC
• UV/VIS Spectrophotometer
• FTIR spectrophotometer
• Polarimeters
• Auto titration systems

Valentis also said its facilities were audited by domestic and international customers and relevant GMP activities were monitored, controlled and audited within its manufacturing operations.

Not every pharma company needs an off-the-shelf, standard chemical. Some projects require special molecules, tailor-made processes or production support. Valentis offers custom synthesis and contract manufacturing services backed by its R&D, manufacturing, analytical and quality capabilities.

This integrated model allows us to support customers from early project stages through process development and optimisation to commercial manufacturing.

Valentis is a supplier of APIs, intermediates and specialty chemicals for pharmaceutical applications to Indian and international drug manufacturers. The company is able to help customers looking for specialised chemical solutions by concentrating on synthesis, research and manufacturing.

Customers can benefit from capabilities such as:

• Knowledge of chemical synthesis
• R&D and manufacturing in-house
• Analytical & quality control support
• Contract manufacturing & custom synthesis
• Experts in complex and niche molecules
• Integrated production and infrastructure support

We are a progressive 2-Methyl-5-nitro-1H-isoindole-1,3 (2H)-dione Manufacturer and are committed to fulfilling the various needs of our customers with the highest quality and service.

Valentis Laboratories combines science, synthesis, research, manufacturing and quality with a clear focus on creating value for its customers. Since inception in 1999, the company has continued to build capabilities in APIs, pharmaceutical intermediates and specialty chemicals to meet the needs of the pharmaceutical industry.

We continue to create value through synthesis for Pharmaceutical and Speciality Chemical customers in India and International markets with a research focused culture, integrated infrastructure, chemical expertise and emphasis on quality.

It’s time to set a new benchmark in chemical production. Tie-up with the leading Manufacturer of 2-Methyl-5-nitro-1H-isoindole-1,3 (2H)-dione today!

Related Page: 3,3-Bis(4-Hydroxyphenyl)-2-Benzofuran-1(3H)-One Manufacturer